Principles of tracer kinetic analysis

Neuroimaging Clinics of North America

Volumn 13, Issue 4, 2003, Pages 689-704

  Price, Julie C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18; OXYGEN 15; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

ALPHA RADIATION; BLOOD SAMPLING; CALIBRATION; CYCLOTRON; GLUCOSE METABOLISM; ISOTOPE LABELING; MATHEMATICAL ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIAL ARTERY; RECEPTOR INTRINSIC ACTIVITY; REVIEW; VENOUS BLOOD;

EID: 0345276635     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5149(03)00107-2     Document Type: Review

References (101)

1. Jones T. Historical development of functional in vivo studies using positron-emitting tracers. In: Valk PE, Bailey DL, Townsend DW, Maisey MN, editors. Positron emission tomography basic science and clinical practice. London: Springer; 2003. p. 147-79.
2. Iacoboni M, Baron JC, Frackowiak RS, Mazziotta JC, Lenzi GL. Emission tomography contribution to clinical neurology. Clin Neurophysiol 1999;110(1): 2-23.
3. Mazziotta JC. Positron emission tomography studies of the brain. In: Phelps ME, Mazziotta JC, Schelbert HR, editors. Positron emission tomography and autoradiography: principles and applications for the brain and heart. New York: Raven Press; 1986. p. 493-579.
4. Bohnen N. Neurologic applications. In: Wahl R, Buchanan J, editors. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 276-97.
5. Laruelle M, Talbot P, Martinez D, Abi-Dargham A. Psychiatric disorders. In: Wahl R, Buchanan J, editors. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 298-319.
6. Tipler P. Modern physics. New York: Worth Publishers; 1978.
7. Phelps M. Emission computed tomography. Semin Nucl Med 1977;7:337-65.
8. Koeppe R. Data analysis and image processing. In: Wahl R, Buchanan J, editors. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 65-99.
9. Links J. Physics and instrumentation of positron emission tomography. In: Frost JJ, Wagner HN, editors. Quantitative imaging: neuroreceptors, neurotransmitters, and enzymes. New York: Raven Press; 1990. p. 37-50.
10. Sorenson J, Phelps M. Physics in nuclear medicine. Orlando (FL): Grune & Stratton; 1987.
11. Friedlander G, Kennedy J, Macias E, Miller J. Nuclear and radiochemisty. 3rd edition. New York: Wiley; 1981.
12. Cember H. Introduction to health physics. 2nd edition. New York: Pergamon Press; 1983.
13. Brucer M. Trilinear chart of the nuclides. St. Louis (MO): Mallinckrodt Chemical Works; 1979.
14. Lassen N, Perl W. Tracer kinetic methods in medical physiology. New York: Raven Press; 1979. p. 104-8.
15. Wang C, Willis D, Loveland W. Radiotracer methodology in the biological, environmental, and physical sciences. Englewood Cliffs (NJ): Prentice-Hall; 1975. p. 326-43.
16. Iwata R. Reference book for PET radiopharmaceuticals. 3rd edition. Sendai, Japan: Cyric Tohoku University; 2002.
17. Sheppard C. Basic principles of the tracer method. New York: Wiley; 1962.
18. Carson R. Tracer kinetic modeling in PET. In: Valk PE, Bailey DL, Townsend DW, Maisey MN, editors. Positron emission tomography basic science and clinical practice. London: Springer; 2003. p. 147-79.
19. Huang SC, Phelps ME. In: Phelps ME, Mazziotta JC, Schelbert HR, editors. Positron emission tomography and autoradiography: principles and applications for the brain and heart. New York: Raven Press; 1986. p. 347-90.
20. Katchalsky A, Curran P. Nonequilibrium thermodynamics in biophysics. Cambridge (MA): Harvard University Press; 1967.
21. Huang S, Barrio J, Phelps M. Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches. J Cereb Blood Flow Metab 1986;6:515-21.
22. Carson RE. PET physiological measurements using constant infusion. Nucl Med Biol 2000;27(7): 657-60.
23. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 1994;14:995-1010.
24. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000;20:423-51.
25. 15O PET studies in baboons: before and after amphetamine. J Nucl Med 2002;43(8):1090-100.
26. 18F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons. Synapse 2001;41(1):1-10.
27. 18F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans. Synapse 2001;41(1):11-21.
28. 3H](-)-cyclofoxy in rat brain in vivo: implications for human studies. J Cereb Blood Flow Metab 1991;11:183-203.
29. Townsend D, Isoardi R, Bendriem B. Volume imaging tomographs. In: Bendriem B, Townsend D, editors. The theory and practice of 3D PET. Boston: Kluwer Academic Publishers; 1998. p. 111-32.
30. Geworski L, Knoop BO, de Wit M, Ivancevic V, Bares R, Munz DL. Multicenter comparison of calibration and cross calibration of PET scanners. J Nucl Med 2002;43(5):635-9.
31. Daube-Witherspoon ME, Karp JS, Casey ME, DiFilippo FP, Hines H, Muehllehner G, et al. PET performance measurements using the NEMA NU 2-2001 standard. J Nucl Med 2002;43(10):1398-409.
32. Carson E, Cobelli C, Finkelstein L. The Mathematical modeling of metabolic and endocrine systems. New York: Wiley Publishers; 1983.
33. Gjedde A, Wong D. Modeling neuroreceptor binding of radioligands in vivo. In: Frost JJ, Wagner HN, editors. Quantitative imaging: neuroreceptors, neurotransmitters, and enzymes. New York: Raven Press; 1990. p. 51-79.
34. Landaw E, DiStefano JJ. I. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol 1984;246:R665-77.
35. Cunningham V, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993;13:15-23.
36. Meikle SR, Matthews JC, Cunningham VJ, Bailey DL, Livieratos L, Jones T, et al. Parametric image reconstruction using spectral analysis of PET projection data. Phys Med Biol 1998;43(3):651-66.
37. Kety S, Schmidt C. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure, and normal values. J Clin Invest 1948;27:476-83.
38. Berne R, Levy M. Physiology. 2nd edition. St. Louis (MO): CV Mosby; 1988.
39. Kety S. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951;3:1-41.
40. Sokoloff L. Cerebral circulation, energy metabolism, and protein synthesis: general characteristics and principles of measurement. In: Phelps ME, Mazziotta JC, Schelbert HR, editors. Positron emission tomography and autoradiography: principles and applications for the brain and heart. New York: Raven Press; 1986. p. 1-71.
41. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
42. Kuhar MJ. Introduction to neurotransmitters and neuroreceptors. In: Frost JJ, Wagner HR, editors. Quantitative imaging: neuroreceptors, neurotransmitters, and enzymes. New York: Raven Press; 1990. p. 1-7.
43. Bennett JP, Yamamura HI. Neurotransmitter, hormone, or drug receptor binding methods. In: Yamamura HI, Enna SJ, Kuhar MJ, editors. Neurotransmitter receptor binding. New York: Raven Press; 1985. p. 61-89.
44. Kuhar M. Autoradiographic localization of drug and neurotransmitter receptors. Trends Neurosc 1981;4:60-4.
45. Young AB, Frey KA, Agranoff BW. In vitro and in vivo. In: Phelps ME, Mazziotta JC, Schelbert HR, editors. Positron emission tomography and autoradiography: principles and applications for the brain and heart. New York: Raven Press; 1986. p. 73-111.
46. Jones SW. Identification of receptors in vitro. In: Eckelman WC, Colombetti LG, editors. Receptor-binding radiotracers. Boca Raton (FL): CRC Press; 1981. p. 15-36.
47. Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002;10(1):24-35.
48. 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 2003;46:2740-54.
49. Renkin E. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959;197:1205-10.
50. Crone C. Permeability of capillaries in various organs as determined by use of the indicator diffution method. Acta Physiol Scand 1964;58:292-305.
51. Mintun M, Raichle M, Kilbourn M, Wooten G, Welch M. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984;15:217-27.
52. Boyce W, DiPrima R. Elementary differential equations. 3rd edition. New York: Wiley Publishers; 1969.
53. Marquardt D. An algorithm for least squares estimation of nonlinear parameters. J Soc Ind Appl Math 1963;2:431-41.
54. Bevington P. Data reduction and error analysis for the physical sciences. New York: McGraw-Hill; 1969.
55. Press W, Flannery B, Teukolsky S, Vetterling W. Numerical recipes the art of scientific computing. Cambridge (UK): Cambridge University Press; 1986. p. 521-8.
56. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980;4:727-36.
57. Huang S, Carson R, Phelps M. Measurement of local blood flow and distribution volume with short-lived isotopes: a general input technique. J Cereb Blood Flow Metab 1982;2:99-108.
58. 15O-water. J Cereb Blood Flow Metab 1983;3:141-53.
59. 2 build-up technique to measure regional cerebral blood flow and volume of distribution. J Cereb Blood Flow Metab 1989;9:461-70.
60. 15O. I. Theory and error analysis. J Nucl Med 1983;24:782-9.
61. Alpert N, Eriksson L, Chang J, Bergstrom M, Litton J, Correia J, et al. Strategy for the measurement of regional cerebral blood flow using short-lived tracers and emission tomography. J Cereb Blood Flow Metab 1984;4:28-34.
62. Carson R, Huang S, Green M. Weighted integration method for local cerebral blood flow measurements with positron emission tomography. J Cereb Blood Flow Metab 1986;6:245-58.
63. Koeppe R, Holden J, Ip W. Performance comparison of parameter estimation techniques for the quantification of local cerebral blood flow by dynamic positron computed tomography. J Cereb Blood Flow Metab 1985;5:224-34.
64. 15O]water clearance in humans determined by PET I. Theory and normal values. J Cereb Blood Flow Metab 1996;16:765-80.
65. Ohta S, Meyer E, Thompson C, Gjedde A. Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen. J Cereb Blood Flow Metab 1992;12:179-92.
66. 15O autoradiography and positron emission tomography, with respect to the dispersion of the input function. J Cereb Blood Flow Metab 1986;6:536-45.
67. 15O]water and dynamic positron emission tomography. J Cereb Blood Flow Metab 1988;8:285-8.
68. 2. A convenient synthesis of 2-deoxy-2-fluoro-D-glucose. J Org Chem 1977;42:2341-2.
69. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979;44:127-37.
70. Kuhl D, Phelps M, Hoffman E, Robinson G, MacDonald N. Initial clinical experience with (F-18)-2-deoxy-D-glucose for determination of local cerebral glucose utilization by emission computed tomography. Acta Neurol Scand 1977;64(Suppl):192-3.
71. Phelps M, Hoffman E, Huang S, Kuhl D. Positron tomography: an "in vivo" autoradiographic approach to measurement of cerebral hemodynamics and metabolism. Acta Neurol Scand 1977;64(Suppl):446-7.
72. Phelps M, Huang S, Hoffman E, Selin C, Sokoloff L, Kuhl D. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose. Ann Neurol 1979;6:371-88.
73. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238(1):E69-82.
74. 18F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose. J Cereb Blood Flow Metab 2001;21(8): 995-1002.
75. Graham MM, Muzi M, Spence AM, O'Sullivan F, Lewellen TK, Link JM, et al. The FDG lumped constant in normal human brain. J Nucl Med 2002;43(9): 1157-66.
76. Hutchins G, Holden J, Koeppe R, Halama J, Gatley S, Nickles R. Alternative approach to single-scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia. J Cereb Blood Flow Metab 1984;4:35-40.
77. Hunter G, Hamberg L, Alpert N, Choi N, Fischman A. Simplified measurement of deoxyglucose utilization rate. J Nucl Med 1996;37(6):950-5.
78. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991;11:735-44.
79. 18F]-cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 1993;13:24-42.
80. 11C]raclopride studies. J Cereb Blood Flow Metab 1996;16:42-52.
81. 11C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab 2001;21(11):1342-53.
82. 11C]WAY-100635 in humans: comparison of arterial and reference issue input functions. J Cereb Blood Flow Metab 2000;20(7):1111-33.
83. Szabo Z, Ravert HT, Gozukara I, Geckle W, Seki C, Sostre S, et al. Noncompartmental and compartmental modeling of the kinetics of carbon-11 labeled pyrilamine in the human brain. Synapse 1993;15(4): 263-75.
84. 18F]FDG kinetics for heart and brain studies with PET. IEEE Trans Biomed Eng 1998;45(12):1429-48.
85. Carson R. PET parameter estimation using linear integration methods: bias and variability. In: Uemura K, Lassen NA, Jones T, Kanno I, editors. Quantification of brain function: tracer kinetic and image analysis in brain PET. New York: Excerpta Medica; 1993. p. 499-507.
86. Slifstein M, Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med 2000;41(12):2083-8.
87. Logan J, Fowler JS, Volkow ND, Ding YS, Wang GJ, Alexoff DL. A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab 2001;21(3):307-20.
88. Blomqvist G, Pauli S, Farde L, Erikkson L, Persson A, Halldin C. Maps of receptor binding parameters in the human brain-kinetic analysis of PET measurements. Eur J Nucl Med 1990;16:257-65.
89. Cunningham V, Hume S, Price G, Randall G, Cremer J, Jones A. Compartmental analysis of diprenorpine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. J Cereb Blood Flow Metab 1991;11:1-9.
90. Lammertsma A, Hume S. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4:153-8.
91. Gunn R, Lammertsma A, Hume S, Cunningham V. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997;6:279-87.
92. 11C]WAY-100635. Neuroimage 1998;8:426-40.
93. 11C]WAY-100635 PET studies. Nucl Med Biol 2000;27:477-82.
94. Patlak C, Blasberg R. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 1985;5:584-90.
95. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990;10:740-7.
96. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Atexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16(5):834-40.
97. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 2000;27(7):661-70.
98. Ichise M, Ballinger JR. From graphical analysis to multilinear regression analysis of reversible radioligand binding. J Cereb Blood Flow Metab 1996;16(4):750-2.
99. Varga J, Szabo Z. Modified regression model for the Logan plot. J Cereb Blood Flow Metab 2002;22(2): 240-4.
100. Ichise M, Toyama H, Innis RB, Carson RE. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab 2002;22(10):1271-81.
101. Carson RE. Precision and accuracy considerations of physiological quantitation in PET. J Cereb Blood Flow Metab 1991;11(2):A45-50.